Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Mosha, Fausta ^a,b   Muchunguzi, Victor ^a   Matee, Mecey ^c   Sangeda, Raphael Z ^b,c   Vercauteren, Jurgen ^b   Nsubuga, Peter ^d   Lyamuya, Eligius ^c   Vandamme, Anne Mieke ^b,e  

^a MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d Global Public Health Solutions   (United States)

^e INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH DISPARITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS; TANZANIA; TIME; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HIV INFECTIONS; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; TANZANIA; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

MLCS; MLOWN;

EID: 84872150549     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-38     Document Type: Article

References (22)

1. Declining morbidity and mortality among patients with advanced Human Immunodeficiency Virus infections. Palella F, Delaney K, Moorman A, N Engl J Med 1998 338 853 860 10.1056/NEJM199803263381301 9516219
2. Five Years of the National Care and Treatment Plan Tanzania (2003-2008): Success and Challenges. NACP, National AIDS Control Programme, AIDS 2009 35 856 4311
3. Predictors of short-term success of antiretroviral therapy in HIV infection. Oette M, Kroidl A, Göbels K, J Antimicrob Chemother 2006 58 147 153 10.1093/jac/dkl189 16687458
4. National Guidelines for the Clinical Management of HIV and AIDS, National Aids Control Programme (NACP) Tanzania: Ministry of Health and Social Welfare Tanzania 2005 and 2009
5. Disease Staging System for HIV Infection and Disease. World Health Organization, 2006 http://www.who.org
6. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. Stringer J, Zulu I, Levy J, JAMA 2006 296 782 793 10.1001/jama.296.7.782 16905784
7. Survival differences in patients with AIDS. Friedland G, Saltzman B, Vileno J, J Acquir Immune Defic Syndr 1991 4 2 144 153 1987352
8. Gender differences in clinical progression of HIV-1 infected individuals during long-term highly active antiretroviral therapy. Nicastri E, Angeletti C, Palmisano L, AIDS 2005 19 577 583 10.1097/01.aids.0000163934.22273.06 15802976
9. Gender differences in survival among adult patients starting antiretroviral therapy in south Africa: a multicentre cohort study. Cornell M, Schomaker M, Garone D, PLOS Medicine 2012 9 1001304 10.1371/journal.pmed.1001304 22973181
10. Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa. Maman D, Pujades-Rodriguez M, Subtil F, PLoS One 2012 7 2 31078 10.1371/journal.pone.0031078 22363550
11. Male gender and the risk of mortality among individuals enrolled in antiretroviral treatment programs in Africa: a systematic review and meta-analysis. Druyts E, Dybul M, Kanters S, AIDS 2012 26 000 000
12. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? Mocroft A, Gill M, Davidson W, Phillips N, JAIDS J Acquir Immune Defic Syndr 2000 24 475 482
13. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzania setting. Hawkins C, Chalamilla G, Okuma J, AIDS 2011 25 1189 1197 10.1097/QAD.0b013e3283471deb 21505309
14. Predictors of HIV disease progression in women. Clark R, Blakley S, Rice J, Brandon W, AIDS 1994 9 43 50
15. Tanzania Commission for AIDS, Tanzania Health Indicator Survey (THIS) USA: Macro International Inc TACAIDS and Tanzania Bureau of Statistics, 2007/2008. 2008
16. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. Morlat P, Parneix P, Douard D, AIDS 1992 6 1187 1193 10.1097/00002030-199210000-00020 1466851
17. Effect of Improved access to Antiretroviral Therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. Mugusi S, Mwita J, Francis J, BMC Public Health 2010 291 10 1471 2458
18. Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Alibhai A, Kipp W, Saunders D, International J Women's Health 2010 2 45 52 23510792
19. Adherence and plasma HIV RNA responses to Highly active antiretroviral therapy among HIV-1 infected injection drug users. Wood E, Montaner J, Yip B, Cmaj 2003 169 7 656 661 14517122
20. Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. Theresa W, Stefan G, Nicholas J, BMC Health Serv Res 2006 6 19 10.1186/1472-6963-6-19 16504167
21. Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol, Potential immunopathogenic mechanisms. Bagasra O, Bachman S, J Infect Dis 1996 173 3 550 558 10.1093/infdis/173.3.550 8627016
22. Does patient Sex affect human immunodeficiency virus levels? Gandhi M, Bacchetti P, Miotti P, Clin Infect Dis 2002 35 313 322 10.1086/341249 12115098